David Krasne

David Krasne is a seasoned business professional based in the New York City Metropolitan Area. He is the Co-Founder and Partner at RedNest Partners, a position he has held since October 2016.1 Krasne is also the Co-Founder and Chief Financial Officer of Nanocan Therapeutics Corporation, located in Princeton, New Jersey.1

Career Highlights

• Co-Founder and Director of Sentire Medical Systems (2017 - Present)1
• Director at Tecmotiv in Niagara Falls, New York (July 2019 - Present)1
• Co-Founder and Director of ExpertConnect (2012 - 2021)1
• CEO and Director of American Medical Forensic Specialists (2010 - 2016)1

Previous Experience

Krasne has held various leadership positions in finance and private equity:

• Vice President at The Riverside Company (2006 - 2008)1
• Principal at Merrill Lynch Global Private Equity (2000 - 2004)1
• Investment Banking Analyst at Merrill Lynch & Co. (1995 - 1998)1

Education

• MBA from UCLA Anderson School of Management1
• BS from Penn State University1

David Krasne's diverse experience spans healthcare, finance, and entrepreneurship, demonstrating his versatility in business leadership roles.